BOC Healthcare goes digital with myCOPD, and gets approved by the NHS Digital library

BOC Healthcare has teamed up with my mhealth to begin delivering myCOPD within NHS community-based pulmonary rehabilitation services. It is currently the only app approved on the NHS Digital tool library.

According to the company this is the first time in the UK that a service provider has created a digital and face-to-face hybrid product.

myCOPD is a self-management solution that enables patients to learn more about their condition, receive expert education, access a home-based pulmonary rehabilitation option, and learn how to take medication correctly.

Ian Thompson, strategic director commented “It is great news to announce this working relationship with BOC Healthcare. Delivering these new models of care, with conventional providers enables patients to receive high quality healthcare at a time that suits them.

“This enables the delivery of rehabilitation at scale, for reduced cost, and at the same time expanding the reach of pulmonary rehabilitation to all patients with COPD.”

BOC Healthcare, commented “As a provider of NHS Pulmonary Rehabilitation services across 10 CCGs, we see everyday the outcomes possible for people attending our group-based programmes, however, not all patients are able to attend them. myCOPD gives us an option, with structured clinical support, to offer those patients, meaning that they don’t miss out on the health benefits which a structured pulmonary rehabilitation and self-management programme can deliver. It importantly gives us a tool to offer people completing group-based programmes to help them maintain their achievements from pulmonary rehabilitation.”



Lu oversees the content for all of the publications within the Rapid Life Sciences portfolio, which includes Digital Health Age, Medical Plastics News, Med-Tech Innovation Magazine and European Pharmaceutical Manufacturer. Reach Lu at

'BOC Healthcare goes digital with myCOPD, and gets approved by the NHS Digital library' has no comments

Be the first to comment this post!

Would you like to share your thoughts?

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

© 2019 Rapid Life Sciences Ltd, a Rapid News Group Company. All Rights Reserved.

Privacy policy

Terms and conditions